Hunan Hansen Pharmaceutical Co., Ltd. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was CNY 311.730 million compared to CNY 419.493 million a year ago. Operating income was CNY 64.709 million compared to CNY 86.314 million a year ago. Net income was CNY 53.230 million compared to CNY 71.900 million a year ago. Basic earnings per share from continuing operations was CNY 0.1058 compared to CNY 0.1429 a year ago.